Diabetic Gastroparesis Study with Tranzyme, Inc.:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of Once-Daily Administration of TZP 102 for the Treatment of Symptoms Associated with Diabetic Gastroparesis.